Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,419.13 156.57 0.96%
S&P 500 1,860.27 17.29 0.94%
NASDAQ 4,085.02 50.86 1.26%
Ticker Volume Price Price Delta
STOXX 50 3,139.26 47.74 1.54%
FTSE 100 6,584.17 42.56 0.65%
DAX 9,317.82 144.11 1.57%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

Warner Chilcott to Present at the 31st Annual J.P. Morgan Healthcare Conference



Warner Chilcott to Present at the 31st Annual J.P. Morgan Healthcare
Conference

DUBLIN, Ireland, Jan. 2, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc
(Nasdaq:WCRX) today announced that Roger Boissonneault, President and Chief
Executive Officer, and Paul Herendeen, Executive Vice President and Chief
Financial Officer, are scheduled to speak at the 31^st Annual J.P. Morgan
Healthcare Conference on Tuesday, January 8th at 7:30 a.m. PST (10:30 a.m.
EST).

The presentation will be simultaneously webcast at
http://ir.wcrx.com/events.cfm, with an archived replay of the webcast
available shortly thereafter at http://ir.wcrx.com/events.cfm.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently
focused on the women's healthcare, gastroenterology, urology and dermatology
segments of the branded pharmaceuticals market, primarily in North America. We
are a fully integrated company with internal resources dedicated to the
development, manufacture and promotion of our products. WCRX-G

CONTACT: Rochelle Fuhrmann
         Investor Relations
         973-442-3281
         rfuhrmann@wcrx.com

Warner Chilcott Logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement